Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment

Published:2020-04 Issue: Volume:286 Page:112890
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Ghabrash Maykel Farag,Coronado-Montoya Stephanie,Aoun John,Gagné Andrée-Anne,Mansour Flavi,Ouellet-Plamondon Clairélaine,Trépanier Annie,Jutras-Aswad Didier

Funder

Université de Montréal's Faculty of Medicine

Fonds de Recherche du Québec en Santé

(

FRQS

)

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference56 articles.

1. Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program;Abdel-Baki;Psychiatry Res.,2017

2. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies;Alvarez-Jimenez;Schizophr. Res.,2012

3. Diagnostic and Statistical Manual of Mental Disorders,2013

4. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis;Black;Lancet Psychiatry,2019

5. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial;Boggs;Psychopharmacology,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights of Cannabinoid CBD: The Pharmacological Potential and Heterologous Expression;Orbital: The Electronic Journal of Chemistry;2024-06-26

2. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder;Schizophrenia Bulletin;2024-06-20

3. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07

4. The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review;Brain Sciences;2024-04-03

5. Exploring the Therapeutic Potential of Cannabigerol in Neurodegenerative Diseases;J BIOL REG HOMEOS AG;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3